T1	Outcomes 0 19	Efficacy and safety
T2	Outcomes 515 531	disease response
T3	Outcomes 551 565	response rates
T4	Outcomes 848 935	the overall response rate [complete clinical response (CCR) plus partial response (PR)]
T5	Outcomes 1157 1158	.
T6	Outcomes 1159 1174	Total UVA doses
T7	Outcomes 1291 1295	arm.
T8	Outcomes 1296 1314	The safety profile
T9	Outcomes 1330 1359	with few grade 3-4 toxicities
T10	Outcomes 1382 1383	.
T11	Outcomes 1384 1414	More drop-outs due to toxicity
T12	Outcomes 1486 1522	The best overall response (CCR + PR)
T13	Outcomes 1588 1595	0·57).
T14	Outcomes 1596 1627	The median duration of response
T15	Outcomes 1696 1704	= 0·33)
T16	Outcomes 1754 1764	PUVA alone
T17	Outcomes 1791 1810	combination therapy
T18	Outcomes 1821 1832	(P = 0·45)
T19	Outcomes 1920 1957	fewer PUVA sessions needed to achieve
T20	Outcomes 2079 2105	lower UVA dose required to
T21	Outcomes 2265 2316	significant difference in response rate or response
T22	Outcomes 2375 2436	trend towards fewer PUVA sessions and lower UVA dose required
